- Home
- LOCO vs HUMA Comparison
LOCO vs HUMA Comparison
Compare LOCO & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOCO
- HUMA
- Stock Information
- Founded
- LOCO 1980
- HUMA 2004
- Country
- LOCO United States
- HUMA United States
- Employees
- LOCO N/A
- HUMA N/A
- Industry
- LOCO Restaurants
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- LOCO Consumer Discretionary
- HUMA Health Care
- Exchange
- LOCO Nasdaq
- HUMA Nasdaq
- Market Cap
- LOCO 270.6M
- HUMA 221.8M
- IPO Year
- LOCO 2014
- HUMA N/A
- Fundamental
- Price
- LOCO $10.50
- HUMA $2.67
- Analyst Decision
- LOCO Buy
- HUMA Strong Buy
- Analyst Count
- LOCO 3
- HUMA 7
- Target Price
- LOCO $15.50
- HUMA $13.00
- AVG Volume (30 Days)
- LOCO 308.1K
- HUMA 5.4M
- Earning Date
- LOCO 05-01-2025
- HUMA 05-13-2025
- Dividend Yield
- LOCO N/A
- HUMA N/A
- EPS Growth
- LOCO 6.54
- HUMA N/A
- EPS
- LOCO 0.86
- HUMA N/A
- Revenue
- LOCO $476,032,000.00
- HUMA $517,000.00
- Revenue This Year
- LOCO $6.21
- HUMA N/A
- Revenue Next Year
- LOCO $1.20
- HUMA $896.45
- P/E Ratio
- LOCO $12.24
- HUMA N/A
- Revenue Growth
- LOCO 1.22
- HUMA N/A
- 52 Week Low
- LOCO $8.29
- HUMA $1.15
- 52 Week High
- LOCO $14.25
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- LOCO 67.39
- HUMA 69.67
- Support Level
- LOCO $9.38
- HUMA $2.41
- Resistance Level
- LOCO $9.93
- HUMA $2.88
- Average True Range (ATR)
- LOCO 0.32
- HUMA 0.30
- MACD
- LOCO 0.15
- HUMA 0.10
- Stochastic Oscillator
- LOCO 94.77
- HUMA 87.43
About LOCO El Pollo Loco Holdings Inc.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. Restaurant locations are typically free-standing and include drive-thrus, and menus include many low-priced options. Poultry is the company's largest food cost, accounting for roughly 38% of total food and paper cost, and the company manages that commodity price risk by using multiple suppliers and entering supply contracts of varying lengths depending on market conditions.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.